Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.99
AEON Biopharma, Inc. shareholders approved Ratification of appointment of KPMG LLP as independent registered public accounting firm for fiscal year 2026 at the 2026-06-17 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-06-17
Exact text from the filing
Proposal 2: The stockholders of the Company ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ended December 31, 2026. The voting results for this proposal were as follows: For Against Abstain Broker Non-Vote 21,502,418 18,217 1,498 —
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.99
AEON Biopharma, Inc. shareholders approved Election of Class III Directors at the 2026-06-17 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-06-17
Exact text from the filing
Proposal 1: The stockholders of the Company elected each of Marc Forth and Seongsoo Park as Class III directors of the Company’s board of directors (the “Class III Directors”) for a three-year term ending at the Annual Meeting of Stockholders to be held in 2029 and until their respective successors have been duly elected and qualified. The voting results with respect to the election of the Class III Directors were as follows: Nominee Term Expiring For Withheld Broker Non-Vote Marc Forth 2029 13,297,322 27,738 8,197,073 Seongsoo Park 2029 13,117,299 207,761 8,197,073
View on SEC.gov